25/11/2014 22:00:41 Free Membership Login

I G I News (AMEX:IG)

DateTimeSource
Headline
11/24/20148:00AMPRNUSIGI Laboratories, Inc. Announces ANDA Submission
IGI Laboratories, Inc. Announces ANDA Submission PR Newswire BUENA, N.J., Nov. 24, 2014 BUENA, N.J., Nov. 24, 2014 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based specialty generic pharmaceutical company, today announced it has submitted an additional abbreviated new drug application (ANDA) to... More...>>
11/13/20148:00AMPRNUSIGI Laboratories Ranked Number 256 Fastest Growing Company In North America On Deloitte 2014 Technology Fast 500™
IGI Laboratories Ranked Number 256 Fastest Growing Company In North America On Deloitte 2014 Technology Fast 500™ Attributes 382 Percent Revenue Growth from 2009 to 2013 to Successful Transformation of IGI into a Specialty Generic Pharmaceutical Company PR Newswire BUENA, N.J., Nov. 13, 2014 BUENA, N.J., Nov. 13, 2014... More...>>
10/23/20144:05PMPRNUSIGI Laboratories Announces Third Quarter 2014 Results
IGI Laboratories Announces Third Quarter 2014 Results PR Newswire BUENA, N.J., Oct. 23, 2014 BUENA, N.J., Oct. 23, 2014 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based specialty generic pharmaceutical company, announced its financial results for the third quarter ended September 30, 2014. Third... More...>>
10/20/20148:00AMPRNUSIGI Laboratories To Hold Conference Call For 3rd Quarter 2014 Results
IGI Laboratories To Hold Conference Call For 3rd Quarter 2014 Results PR Newswire BUENA, N.J., Oct. 10, 2014 BUENA, N.J., Oct. 10, 2014 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based specialty generic pharmaceutical company, announced the Company will hold a conference call at 4:15 pm ET on... More...>>
10/10/20148:00AMPRNUSIGI Laboratories To Hold Conference Call For 3rd Quarter 2014 Results
IGI Laboratories To Hold Conference Call For 3rd Quarter 2014 Results PR Newswire BUENA, N.J., Oct. 10, 2014 BUENA, N.J., Oct. 10, 2014 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based specialty generic pharmaceutical company, announced the Company will hold a conference call at 4:15 pm ET on... More...>>
10/09/20144:05PMPRNUSIGI Laboratories, Inc. Appoints Steven Koehler To Board Of Directors
IGI Laboratories, Inc. Appoints Steven Koehler To Board Of Directors PR Newswire BUENA, N.J., Oct. 9, 2014 BUENA, N.J., Oct. 9, 2014 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey-based specialty generic pharmaceutical company, today announced that it has appointed Steven Koehler to its Board of Directors... More...>>
10/01/20148:00AMPRNUSIGI Laboratories, Inc. Acquires Two Products From Valeant Pharmaceuticals
IGI Laboratories, Inc. Acquires Two Products From Valeant Pharmaceuticals PR Newswire BUENA, N.J., Oct. 1, 2014 BUENA, N.J., Oct. 1, 2014 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based specialty generic pharmaceutical company, today announced it has acquired two previously marketed ophthalmic... More...>>
09/25/20148:30AMPRNUSIGI Laboratories, Inc. Acquires Eighteen Former Products From AstraZeneca
IGI Laboratories, Inc. Acquires Eighteen Former Products From AstraZeneca PR Newswire BUENA, N.J., Sept. 25, 2014 BUENA, N.J., Sept. 25, 2014 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based specialty generic pharmaceutical company, today announced it has acquired the regulatory rights and related... More...>>
07/24/20144:02PMPRNUSIGI Laboratories Announces Second Quarter 2014 Results
IGI Laboratories Announces Second Quarter 2014 Results PR Newswire BUENA, N.J., July 24, 2014 BUENA, N.J., July 24, 2014 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based specialty generic drug development and manufacturing company, announced its financial results for the second quarter ended June... More...>>
07/24/20144:02PMPRNUSIGI Laboratories, Inc. Announces Change To Its Board Of Directors
IGI Laboratories, Inc. Announces Change To Its Board Of Directors PR Newswire BUENA, N.J., July 24, 2014 BUENA, N.J., July 24, 2014 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based specialty generic pharmaceutical company, today announced it has accepted  Damian Finio's resignation from its Board... More...>>
07/18/20148:00AMPRNUSIGI Laboratories To Hold Conference Call For 2nd Quarter 2014 Results
IGI Laboratories To Hold Conference Call For 2nd Quarter 2014 Results PR Newswire BUENA, N.J., July 18, 2014 BUENA, N.J., July 18, 2014 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based topical generic drug development and manufacturing company, announced the Company will hold a conference call... More...>>
07/02/20144:05PMPRNUSIGI Laboratories Announces Closing Of Underwritten Offering Including Over-Allotment Option
IGI Laboratories Announces Closing Of Underwritten Offering Including Over-Allotment Option PR Newswire BUENA, N.J., July 2, 2014 BUENA, N.J., July 2, 2014 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE MKT: IG; IGI or the Company), today announced the closing of its previously announced underwritten public offering of... More...>>
06/30/20142:08PMPRNUSIGI Laboratories Added To The Russell 3000 Index
IGI Laboratories Added To The Russell 3000 Index PR Newswire BUENA, N.J., June 30, 2014 BUENA, N.J., June 30, 2014 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE MKT: IG; IGI or the Company), a specialty generic topical pharmaceutical company, has been added as a member of the broad-market Russell 3000® Index after the... More...>>
06/27/20148:04AMPRNUSIGI Laboratories Prices $23.3 Million Underwritten Offering
IGI Laboratories Prices $23.3 Million Underwritten Offering PR Newswire BUENA, N.J., June 27, 2014 BUENA, N.J., June 27, 2014 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE MKT: IG; IGI or the Company), today announced the pricing of its previously announced underwritten public offering of 4,650,000 shares of its common... More...>>
06/26/20144:07PMPRNUSIGI Laboratories Announces Public Offering Of Common Stock
IGI Laboratories Announces Public Offering Of Common Stock PR Newswire BUENA, N.J., June 26, 2014 BUENA, N.J., June 26, 2014 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE MKT: IG; IGI or the Company), today announced that it is offering shares of the Company's common stock in an underwritten public offering. The proposed... More...>>
06/26/20148:30AMPRNUSIGI Laboratories, Inc. Announces Joint Stipulation
IGI Laboratories, Inc. Announces Joint Stipulation PR Newswire BUENA, N.J., June 26, 2014 BUENA, N.J., June 26, 2014 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based generic topical pharmaceutical company, today announced that it has entered into an agreement with Mallinckrodt LLC, Mallinckrodt... More...>>
06/20/20148:30AMPRNUSIGI Laboratories, Inc. Announces 18th and 19th ANDA Submissions
IGI Laboratories, Inc. Announces 18th and 19th ANDA Submissions PR Newswire BUENA, N.J., June 20, 2014 BUENA, N.J., June 20, 2014 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based generic topical pharmaceutical company, today announced it has submitted two additional abbreviated new drug application... More...>>
06/20/20148:00AMPRNUSIGI Laboratories, Inc. Completes Its Seventh ANDA Filing For 2014 Under Joint Drug Development And Commercialization Agreemen...
IGI Laboratories, Inc. Completes Its Seventh ANDA Filing For 2014 Under Joint Drug Development And Commercialization Agreement With Impax Laboratories, Inc. PR Newswire BUENA, N.J. and HAYWARD, Calif., June 20, 2014 BUENA, N.J. and HAYWARD, Calif., June 20, 2014 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE MKT: IG), a... More...>>
06/19/20148:00AMPRNUSIGI Laboratories, Inc. Announces Fourth ANDA Submission In 2014
IGI Laboratories, Inc. Announces Fourth ANDA Submission In 2014 PR Newswire BUENA, N.J., June 19, 2014 BUENA, N.J., June 19, 2014 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based generic topical pharmaceutical company, today announced it has submitted another abbreviated new drug application (ANDA... More...>>
06/18/20148:30AMPRNUSIGI Laboratories, Inc. Announces Sixteenth ANDA Submission
IGI Laboratories, Inc. Announces Sixteenth ANDA Submission PR Newswire BUENA, N.J., June 18, 2014 BUENA, N.J., June 18, 2014 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based generic topical pharmaceutical company, today announced it has submitted its third abbreviated new drug application (ANDA... More...>>


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us amex ig141125 22:00